Open Access
SHS Web Conf.
Volume 86, 2020
ICORE 2019 – The International Conference on Rural Development and Entrepreneurship
Article Number 01004
Number of page(s) 7
Published online 20 November 2020
  1. Baumann, M. U., Bersinger, N. A., Mohaupt, M. G., Raio, L., Gerber, S., & Surbek, D. V. (2008). First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia. American Journal of Obstetrics & Gynecology, 199(3), 266.e261266.e266. doi:10.1016/j.ajog.2008.06.069 [CrossRef] [Google Scholar]
  2. Cunningham FG., Leveno KJ., Bloom S., Hauth JC., Rouse D., & Spong C. (2014). Pregnancy Hypertension Williams Obstetrics (Vol. 24th ed, pp. 728). United states of America: McGraw Hill Medical Companies. [Google Scholar]
  3. Dinas Kesehatan Jawa Tengah. (2016). Profil Kesehatan Jawa Tengah, 2015. Retrieved from ng_2016.pdf. [Google Scholar]
  4. Dinas Kesehatan Jawa Timur. (2016). Profil Kesehatan Jawa Timur, 2015. Retrieved from 2015/15_Jati m_2015.pdf. [Google Scholar]
  5. Duley, L. (2009). The Global Impact of Pre-eclampsia and Eclampsia. Seminars in Perinatology, 33(3), 130-137. doi: [CrossRef] [Google Scholar]
  6. Feng, H., Wang, L., Zhang, M., Zhang, Z., Guo, W., & Wang, X. (2017). Ratio of matrix metalloproteinase-2 to -9 is a more accurate predictive biomarker in women with suspected pre-eclampsia. Bioscience reports, 37(2), BSR20160508. doi:10.1042/BSR20160508 [CrossRef] [Google Scholar]
  7. Hirashima, C., Ohkuchi, A., Matsubara, S., Suzuki, H., Takahashi, K., Usui, R., & Suzuki, M. (2008). Alteration of Serum Soluble Endoglin Levels after the Onset of Preeclampsia Is More Pronounced in Women with Early-Onset. Hypertension Research, 31, 1541. doi:10.1291/hypres.31.1541 [CrossRef] [Google Scholar]
  8. Kaitu’u-Lino, T. J., Tuohey, L., Ye, L., Palmer, K., Skubisz, M., & Tong, S. (2013). MTMMPs in pre-eclamptic placenta: Relationship to soluble endoglin production. Placenta, 34(2), 168-173. doi:10.1016/j.placenta.2012.11.034 [CrossRef] [Google Scholar]
  9. Kaitu’u-Lino, T. u. J., Palmer, K. R., Whitehead, C. L., Williams, E., Lappas, M., & Tong, S. (2012). MMP-14 Is Expressed in Preeclamptic Placentas and Mediates Release of Soluble Endoglin. The American Journal of Pathology, 180(3), 888-894. doi:10.1016/j.ajpath.2011.11.014 [CrossRef] [Google Scholar]
  10. Kementrian Kesehatan. (2017). Profil Kesehatan Indonesia 2016,. Jakarta Retrieved from Kesehatan-Indonesia-2016.pdf. [Google Scholar]
  11. Lisonkova, S., & Joseph, K. S. (2013). Incidence of preeclampsia: risk factors and outcomes associated with earlyversus late-onset disease. American Journal of Obstetrics & Gynecology, 209(6), 544.e541-544.e512. doi:10.1016/j.ajog.2013.08.019 [CrossRef] [Google Scholar]
  12. Majali-Martinez A., V. P., Pollheimer J., Knofler M., Yung H.W., Burton G.J., Tabrizi-Wizsy N.G., Lang U., Hiden U., Desoye G., Dieber-Rotheneder M. . (2017). Endothelin-1 downregulates matrix metalloproteinase 14 and 15 expression in human first trimester trophoblasts via endothelin receptor type B. Hum. Reprod, 32, 46-54. doi:10.1093/humrep/dew295 [Google Scholar]
  13. Nagase H., V. R., Murphy G. . (2006). Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc. Res., 69, 562-573. doi:10.1016/j.cardiores.2005.12.002 [CrossRef] [PubMed] [Google Scholar]
  14. Palei, A. C. T., Sandrim, V. C., Amaral, L. M., Machado, J. S. R., Cavalli, R. C., Duarte, G., & Tanus-Santos, J. E. (2012). Association between matrix metalloproteinase (MMP)-2 polymorphisms and MMP-2 levels in hypertensive disorders of pregnancy. Experimental and Molecular Pathology, 92(2), 217-221. doi: [CrossRef] [Google Scholar]
  15. Pollheimer, J., Fock, V., & Knöfler, M. (2014). Review: The ADAM metalloproteinases – Novel regulators of trophoblast invasion? Placenta, 35, S57-S63. doi:10.1016/j.placenta.2013.10.012 [CrossRef] [Google Scholar]
  16. Redman C.W.G and Staff A.C. (2018). The Differences Between Earlyand Late-Onset Preeclampsia. In S. Saito (Ed.), Preeclampsia Basic, Genomic, and Clinical (pp. 157-112): Springer, Singapore. [Google Scholar]
  17. Zhang XH, Z. H., Lu S, Jiang LL, Wu J, Yang YL, Zhang SA. (2018). MMP-14 aggravates onset of severe preeclampsia by mediating soluble endoglin release. Eur Rev Med Pharmacol Sci, 22(5), 1209-1215. doi:10.26355/eurrev_201803_14460 [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.